Tevogen Bio Holdings Inc. Files Definitive Proxy Statement
Ticker: TVGNW · Form: DEF 14A · Filed: Apr 30, 2025 · CIK: 1860871
| Field | Detail |
|---|---|
| Company | Tevogen Bio Holdings Inc. (TVGNW) |
| Form Type | DEF 14A |
| Filed Date | Apr 30, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, shareholder-meeting
Related Tickers: TIVO
TL;DR
Tevogen Bio Holdings (TIVO) filed its proxy statement, shareholders vote soon.
AI Summary
Tevogen Bio Holdings Inc. filed its definitive proxy statement on April 30, 2025, for the fiscal year ending December 31, 2024. The company, formerly known as Semper Paratus Acquisition Corp until May 5, 2021, is based in Warren, NJ, and operates in the biological products sector. The filing details information relevant to shareholders regarding company matters.
Why It Matters
This filing provides shareholders with crucial information about the company's governance, executive compensation, and proposals to be voted on at the upcoming shareholder meeting, impacting their investment decisions.
Risk Assessment
Risk Level: medium — Proxy statements are routine filings, but the specific proposals and company performance discussed within can carry significant implications for investors.
Key Numbers
- 20250430 — Filing Date (Date the definitive proxy statement was filed with the SEC.)
- 2024-12-31 — Fiscal Year End (The period covered by the financial information in the proxy statement.)
Key Players & Entities
- Tevogen Bio Holdings Inc. (company) — Registrant
- Semper Paratus Acquisition Corp (company) — Former company name
- 0001860871 (company) — Central Index Key
- 15 Independence Boulevard, Suite 410, Warren, NJ 07059 (company) — Business and mailing address
- 646-807-8832 (company) — Business phone number
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose of this DEF 14A filing is to provide shareholders with a proxy statement, which contains important information regarding the company's annual meeting of shareholders, including proposals to be voted on, executive compensation, and corporate governance matters.
When was Tevogen Bio Holdings Inc. formerly known as Semper Paratus Acquisition Corp?
Tevogen Bio Holdings Inc. was formerly known as Semper Paratus Acquisition Corp until May 5, 2021.
What is the business address of Tevogen Bio Holdings Inc.?
The business address of Tevogen Bio Holdings Inc. is 15 Independence Boulevard, Suite 410, Warren, NJ 07059.
What is the SIC code for Tevogen Bio Holdings Inc.?
The Standard Industrial Classification (SIC) code for Tevogen Bio Holdings Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
What is the filing date of this definitive proxy statement?
This definitive proxy statement was filed on April 30, 2025.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 30, 2025 regarding Tevogen Bio Holdings Inc. (TVGNW).